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Abstract 
Fusobacterium necrophorum is an anaerobic Gram-negative non spore forming rod 
shaped bacteria that is a normal inhabitant of the alimentary tract of humans and animals. Two 
subspecies of F. necrophorum have been recognized- subspecies necrophorum and subspecies 
funduliforme. Subspecies necrophorum is an opportunistic pathogen in animals causing diseases 
such as bovine hepatic abscesses and sheep foot rot while as subspecies funduliforme is linked 
with human oral and hepatic infections such as sore throats, Lemierre’s syndrome and hepatic 
abscesses. The pathogenic mechanisms of F. necrophorum are complex and are not well 
understood or defined. Several virulence factors such as leukotoxin, haemolysin, haemagglutinin 
and adhesin have been described.  
One of the most important factors in F. necrophorum bacterial pathogenesis is the 
adhesion of the bacteria to the host cell. The adhesion of the bacteria to the host cell helps it 
colonize the host tissue and this is followed by intracellular multiplication with dissemination to 
other tissues, which could ultimately lead to septicemia and death. Bacteria use adhesins which 
are proteins found in the outer membrane which help them bind with host receptors and this 
helps with the adhesion of the bacteria to the host cell. Not much is known about F. 
necrophorum adhesins. Here, we describe and characterize a novel adhesin.          
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Chapter 1 - Introduction 
Fusobacterium necrophorum is a Gram-negative, anaerobic and rod shaped bacterium. It 
gets its genus name from the Latin word,”fusus”, which means spindle, although it is not usually 
spindle shaped. F. necrophorum is a normal inhabitant of the ruminant gut flora of cattle, and is 
an opportunistic pathogen, and it is isolated from gastro-intestinal tracts, oral cavities and 
urogenital tracts from humans and animals.  
F. necrophorum has been recognized as an animal pathogen since the late 
1800s(Langworth, 1977). F. necrophorum is a much more common pathogen in animals than in 
humans and is an economically important bacterium to agriculture, as it causes liver abscesses in 
cattle. In feedlots, the average rate of prevalence is between 12-32% but in some cases, rates as 
high as 90-95% have been reported (Brink et al., 1990; Nagaraja and Chengappa, 1998). Liver 
abscesses result in liver condemnation, reduced weight gain(up to 11%), decreased feed 
efficiency (up to 9%) and reduction in the dressing percentage of carcasses, costing 
approximately $66 per head in animals with severe abscesses (Brink et al., 1990). Liver 
abscesses are the leading reason for liver condemnation and account for 50% of all 
condemnations. Livers are usually trimmed to get rid of abscesses, during which time, the 
abscesses may rupture, leading to the condemnation of the entire carcass and putting a huge 
economic burden on the meat packer. 
 Footrot is prevalent in sheep, goats and cattle, and to a certain extent, in horses 
(Bennett 2011). The hard keratin of the hoof is destroyed leading to lameness in the animal. It is 
thought to be caused by the synergistic interaction between two bacteria- Dichelobacter nodosus 
and F. necrophorum. Footrot is a contagious and debilitating disease (Zhou 2009) that causes 
losses in production and raises animal welfare issues. Recently, Zhou et al. have shown that F. 
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necrophorum is also involved in lameness in pigs, the presence of which was confirmed by 
testing the swabs from the lame hooves of six pigs for the presence of F. necrophorum 
leukotoxin gene by PCR (Zhou 2010). In pen trials, it has been shown that F. necrophorum is 
required for D. nodosus to establish a successful footrot infection (Roberts and Egerton 1969).      
Evaluation of aerobic and anaerobic flora from liver abscesses has shown that F. 
necrophorum is the primary etiologic agent, with an isolation range ranging from 81-100%. In 
many cases, F. necrophorum is isolated as the sole pathogen, occasionally being isolated with a 
variety of both aerobic and anaerobic facultative bacteria (Scanlan and Hathcock 1983). F. 
necrophorum is also described as the cause of calf diphtheria (Loeffler), foot rot in cattle and 
sheep and hog cholera (Bang) 
In humans, F. necrophorum accounts for <1% of bacteremia cases, with only a (few) 
hundred reported cases in the literature. However, among non-spore forming anaerobes, it is 
unique in having a very strong association with several clinically distinctive septicemic 
infections known as necrobacillosis, postanginal sepsis, or Lemierres syndrome (Riordan 2007). 
The human isolate of F. necrophorum subspecies funduliforme was first described by Jean Halle 
in 1898 as part of his Ph.D thesis on the bacteriology of the female genital tract.  
A paper by Courmont and Cade (1900) is regarded as the first paper to describe 
Lemierre’s Syndrome, which is postanginal septicemic infection with F. necrophorum. 
Lemierre’s syndrome is also known as postanginal shock or human necrobacillosis and it usually 
occurs in children and young adults. The paper described a patient who complained of sore throat 
and cough. A few days later, there was onset of rigors which progressed to and overwhelming 
sepsis and caused a large abscess in the supraclavicular fossa. On autopsy, the lungs had multiple 
abscesses, which were thought to be septic emboli infarctions. Courmont and Cade were further 
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able to demonstrate the bacteria in the pus were anaerobic Gram-negative bacilli, which they 
then used to infect other animals. The colonies described were consistent with F. necrophorum. 
Lemierre’s syndrome usually develops after a sore throat episode, usually caused by bacteria 
such as Streptococcus. The bacteria causes a peritonsillar abscess, inside of which, anaerobic 
bacteria such as F. necrophorum are able to flourish. The sore throat is accompanied by purulent 
exudate, high fever, cervical and submandibular lymphadenopathy, that rapidly leads to 
metastatic abscesses. F. necrophorum move from the abscesses into the neighboring tissues, 
including the jugular vein. Here the bacteria can result in the formation of a septic thrombosis. 
Once the thrombus enters the blood stream, it causes bacteremia and emboli are seeded 
throughout the rest of the body. If an emboli enters the pulmonary vasculature, it can block 
branches of the pulmonary artery bringing deoxygenated blood to the lungs from the heart. This 
can cause shortness of breath accompanied by chest pain and could lead to severe pneumonia. 
André Lemierre was the first to describe the disease in 1936 when he published a series of 20 
cases of throat infection followed by anaerobic septicemia, in which 18 of the cases died.  
Initially, there was much confusion about the causative organism, in part due to the many 
names given to F. necrophorum. André Lemierre first misidentified the organism as B. fragilis 
(Lemierre 1929), whereas some German authors referred to it as Bacillus symbiophiles, while 
some French scientists referred to it as Bacillus funduliformis. Such was the confusion that there 
were up to 52 names used to refer to F. necrophorum. The description of the associated cases 
and the properties of the organism lead people to believe that they were describing the same 
organism. Knorr (1923) introduced the genus Fusobacterium for pointed, non-spore forming , 
Gram-negative bacteria found in the mouth. Shinjo et al. (1991) proposed that F. necrophorus 
has two distinct subspecies, F. necrophorum subspecies necrophorum or biotype A and F. 
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necrophorum subspecies funduliforme or biotype B. this was based on differences at the 
biochemical, morphological and DNA homology differences between the two subspecies. His 
group also developed a one-step duplex PCR to detect and differentiate between the two 
subspecies. The separation into two subspecies is also based on the animal of origin of the 
bacteria. While F. necrophorum subspecies necrophorum was isolated from animals, F. 
necrophorum subspecies funduliforme was isolated form humans (Fig 1). 
    
       Pathogenic mechanisms of F. necrophorum 
F. necrophorum is an opportunistic pathogen and it has many virulence factors which 
contribute to its pathogenesis. It is well established that subsp. funduliforme does not possess all 
the virulence factors of subsp. necrophrum and the toxins produced by subsp. funduliforme tend 
to be produced in smaller amounts than those of subsp. necrophrum. This might explain the 
difference in the severity of the infections and diseases between animals and humans caused by 
F. necrophorum. One of the striking aspects of F. necrophorum infections in humans is that it is 
most highly prevalent in a tight cluster based on age as it mainly affects people in the their late 
teens and early 20s. This is obvious not only in cases with Lemierre’s syndrome but also in cases 
of tonsillitis and peritonsillar abscesses. The pathogenic mechanism depends on many bacterial 
and host factors such as bacterial strain, aspects of the host tonsil, presence or absence of 
immunity and synergistic factors.  
 Virulence factors of F. necrophorum 
By definition, virulence factors refer to the properties (i.e., gene products) that enable a 
microorganism to establish itself on or within a host of a particular species and enhance its 
potential to cause disease. Virulence factors include bacterial toxins, cell surface proteins that 
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mediate bacterial attachment, cell surface carbohydrates and proteins that protect a bacterium, 
and hydrolytic enzymes that may contribute to the pathogenicity of the bacterium. Due to the 
economic importance of diseases it causes in animals, work has been done to study the virulence 
factors of F. necrophorum. In humans, not a lot of work has been done to study subsp. 
funduliforme, as the incidences of necrobacillosis and Lemierre’s syndrome are very rare. Pham 
(look up) infected animals with human F. necrophorum isolates and was able to report that in 
animals, the more virulent human strains have an affinity for animal livers and lungs, while the 
less virulent strains seemed to affect joints, bones and muscles of the animals. F. necrophorum 
have a host of virulence factors that it uses to invade a host and establish a successful infection.   
 Leukotoxin 
  The best studied virulence factors of F. necrophorum, leukotoxin was first described by 
Roberts (1967). Since then, the toxins nature and action has been thoroughly characterized. 
Leukotoxin is a high molecular weight secreted protein-336kDa (Narayanan 2001), which is 
toxic to ruminant leukocytes. At very low concentrations, leukotoxin activates 
polymorphonuclear leukocytes (PMNs) and the leukocytes showed changes characteristic of 
apoptosis. At higher concentrations, leukotoxin induces it was shown that bovine mononuclear 
cells were induced to undergo apoptosis. At very high concentrations, leukotoxin causes necrotic 
cell death of bovine peripheral leukocytes. Non-leukotoxin producing strains of F. necrophorum 
are unable to induce foot rot in cattle following inoculation of the bacterium 
intradermally(Emery 1985).  The sequence of the leukotoxin suggests that the leukotoxin is a 
novel protein not related to any other known bacterial leukotoxins or exotoxins.  
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 Endotoxin  
Lipopolysaccharide (LPS) is a very important virulence factor for Gram-negative 
bacteria, and purified LPS from F. necrophorum behaves like a classical endotoxin in animal 
models (Garcia 1975). Tan et al.,(1996) showed a difference between the LPS of F. 
necrophorum subsp necrophorum and subsp funduliforme, both in quantity and composition, 
with subsp necrophorum having higher LPS content than subsp funduliforme. Tan et al., also 
showed that F. necrophorum subsp necrophorum caused greater chicken embryo mortalities than 
that of subsp funduliforme.  
 Hemolysin 
 Divalent metal ions such as iron, magnesium, manganese, cobalt, copper, nickel and 
zinc, to name a few are often required for the survival of the bacteria for both subsp 
necrophorum and subsp funduliforme. These divalent metal ions in trace amounts are needed by 
the bacteria as cofactors for enzymes that catalyze biochemical reactions for various metabolic 
pathways required by the organism. Iron in particular is needed by the bacteria for almost all 
enzymatic and metabolic pathways. Since iron is essential in nature, vertebrates have developed 
elaborate mechanisms to sequester iron in body fluids (eg: transferring in blood and lactoferrin in 
external secretions help sequester free iron). These proteins create an environment depleted of 
iron at a level which is too low to support the growth of nearly all bacteria.  Hemolytic activity is 
very important to F. necrophorum as the bacterium needs to acquire iron from the media to grow 
and multiply. Tan et al., was able to show that in liver abscesses contributed to F. necrophorum 
subsp necrophorum, there was hemolysin activity which appeared to contribute to abscess 
formation.       
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 Hemagglutinin 
 Hemaglutinin refers to a substance that causes red blood cells to agglutinate. The process 
of agglutination is referred to as hemaglutination. Kanoe et al.,1989 has shown data that suggests 
that hemagglutinin is one of the components of the cell surfaces of F. necrophorum subsp 
necrophorum and is probably an outer membrane protein. Kanoe et al.,1989 also examined 
guinea pig mesenteric circulation in-vivo and demonstrated that both cell free hemagglutinin and 
F. necrophorum hemagglutinin could cause thrombus formation. The thrombi were first 
observed in the venules and later on in the arterioles. Immunofluorescence assays showed that 
the hemagglutinin bound to the thrombi in microcirculation and were able to deduce that 
thromobosis is one of the earliest steps in the pathogenesis of necrosis and is an important 
virulence factor for F. necrophorum.     
 Adhesins 
 Adhesion is one of the first steps that a bacterium has to do to for establishing a 
successful colonization. Bacteria produce adhesins, which are proteins that interact with host cell 
receptors and lead to the binding of the bacteria with the host cell. Tan et al., (1996) 
demonstrated the presence of fimbriae on the bacterial surfaces of both subspecies, which could 
be used to bind to the host cell receptor, although the host cell receptor has still not been 
identified.   
 Synergy 
 Since F. necrophorum are well known opportunistic pathogens, many studies have been 
carried out to see if they infect the host better in the presence of other bacteria which might make 
the condition more favorable for F. necrophorum to establish a successful infection. Smith et al., 
showed that F. necrophorum was able to produce fatal necrobacillosis in mice when injected in 
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doses greater than 10
6
 organisms subcutaneously. When the mice were injected with sub-lethal 
doses in either diluted or undiluted broth cultures of other bacteria, especially Escherischia. coli, 
the infective dose to produce necrobacillosis in mice fell to less than 10 organisms of F. 
necrophorum. In the necrobacillosis lesions that developed from co-infection, F. necrophorum 
far outnumbered E. coli. They were also able to show that they achieved a similar synergistic 
effect when F. necrophorum was mixed with other bacteria such as Pseudomonas aeruginosa, 
Bacteriodes fragilis and Fusobacterium nucleatum. In the cases of alpha hemolytic 
Streptococcus and B. fragilis, F. necrophorum increased the persistence of alpha hemolytic 
Streptococcus and B. fragilis in-vivo and enabled the bacteria to multiply profusely showing that 
the synergistic effect was mutually beneficial.  
 TREATMENT AND MANAGEMENT/PREVENTION 
F. necrophorum was a serious human disease in the age of pre-antibiotics. In the current 
day and age of antibiotics, F. necrophorum infections in humans are an uncommon problem and 
Lemierre’s syndrome is rarely reported, with few cases reported, the disease is sometimes 
referred to as “the forgotten disease” (Weesner and Cisek, 1993). The current rate of incidence is 
0.8 cases per million in the general population. In the U.K. 19 cases were reported in 1997 and 
34 cases were reported in 1999.  Prior to antibiotics, the mortality rate was 90%, now thanks to 
antibiotic therapy; mortality has dropped to 15%.  
F. necrophorum, is generally very susceptible to beta-lactam antibiotics, metronidazole, 
clindamycin and third generation cephalosporins. Penicillin is often given as the first line of 
treatment and sometimes Clindamycin is given as monotherapy. There are many conflicting 
scientific studies as to which antibiotic to administer based on in-vitro studies. Many authors 
have a preference for metronidazole as it seems to have an excellent activity against all strains of 
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Fusobacterium species and they also cite excellent tissue penetration by the drug (Freeman et al.. 
1997). There are some concerns about using metronidazole to treat humans (Rustia and Shubik, 
1972), since metronidazole has been found to cause lung tumors and malignant lymphomas in 
mice. Despite this, metronidazole is widely used in Europe to treat Fusobacterium and other 
anaerobic bacterial infections. 
Like many bacteria, Fusobacterium species seem to be gaining resistance to antibiotics. 
Simon, (1977) tested 25 isolates of Fusobacterium against 37 antimicrobials for antibiotic 
susceptibility using the disc diffusion method and reported that Fusobacterium was susceptible 
to 15 antimicrobials and resistant to 12 where as for the remaining 10 antimicrobials, some 
isolates were completely resistant where as others showed partial resistance. Moreno et al., 
(1989) reported that in a study of 11 patients with Lemierre’s syndrome two patients showed 
resistance to ampicillin and treatment with cefoxitin or metronidazole was resumed to cure the 
infection. Brazier (2006) evaluated 100 human isolates of F. necrophorum submitted to the U.K. 
ARL and found a 15% resistance to erythromycin, with a 2% resistance to penicillin and 1% 
resistant to tetracycline. In animals, Sheldon et al., looked at minimum inhibitory concentrations 
(MICs) of candidate antibiotics for the principal bacteria associated with uterine infections. The 
bacteria were isolated from Holstein-Friesian cows which had clinical metritis and/or 
endometritis. They found that F. necrophorum had the highest MIC50 values for enrofloxacin 
and oxytetracycline but had values of 0.06 microgram/ml or below for all cephalosporins. 
Nagaraja et al., (1998) evaluated 37 isolates of F. necrophorum from liver abscesses in cattle and 
showed that subsp necrophorum and subsp funduliforme were both susceptible to 
chlortetracycline, oxytetracycline, tilmicosin, tylosin and virginiamycin, while they were 
somewhat less susceptible to bacitracin, lasalocid and monensin. While the main line for 
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combating F. necrophorum infections is by the administration of antibiotics, this has lead to the 
bacterium gaining resistance to many antibiotics and antimicrobials    
Saginala et al., (1996) did a study using serum antileukotoxin antibody response and 
protection in steers which were vaccinated with a crude F. necrophorum leukotoxoid against a 
subsequent experimental challenge with F. necrophorum. The steers were injected on days 0 and 
21subcutaneously with a concentrated culture supernatant of F. necrophorum containing 
leukotoxoid and were challenged intraportally with F. necrophorum culture on day 42. The 
steers were euthanized on day 63 and their livers were examined for assessment of protection. 
They concluded that antileukotoxin antibody titers provided some degree of protection against 
the induced liver abscesses (8 out of 25 vaccinated steers developed abscesses while as in the 
control group, 3 out of 5 control steers developed abscesses). In another study Saginala et al., 
(1996) determined the efficacy of leukotoxin –based F. necrophorum vaccines in providing 
protection against experimentally induced liver abscesses in steers. They were able to find that 
the culture supernatant vaccine was more effective than whole-cell culture or semipurified 
leukotoxin in protecting the steers against liver abscesses and partial purification of leukotoxin 
appeared to reduce its protective immunity.  
Emerging antimicrobial resistance and an increasing concern in public health and meat 
consumers over the use of antibiotics for growth promotion in feed animals have led several 
European countries to ban the use of antibiotics as growth promoters. The concerns make the 
development of an effective vaccine an important priority. The leukotoxoid vaccine provided 
immunity to the cattle against F. necrophorum infection but it was not 100% effective, providing 
around 43% protection to the animals. Unfortunately, the leukotoxoid vaccine is a crude vaccine 
and contains bacterial components, such as lipopolysaccharide which causes adverse reaction in 
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cattle and other cellular derivatives or debris which causes injection site abscesses and transient 
illness followed by reduced feed intake and weight gain in cattle (Checkley et al., 2005). As a 
result, this vaccine was taken off the market. Another commercially available vaccine 
Fusogard® (Novartis) is a bacterin ( suspension of killed or attenuated bacteria). This vaccine 
demonstrated about a 31.5% reduction in liver abscesses. The protection provided by either 
vaccine is not better than the current method of abscess treatment in cattle (tylosin 
supplementation in cattle diet). 
Considering the current mindset in public health and animal welfare and in the big picture 
against the use of antibiotics for growth promotion and in some cases, for treatment of animal 
diseases, the development of a vaccine which has high efficacy and minimal side effects is 
warranted. Identification of crucial outer membrane proteins required by F. necrophorum to 
adhere to the host surface to start colonization would make an ideal vaccine target if antibodies 
are raised in animals and humans against these proteins. These critical immunodominant outer 
membrane protein/proteins, once identified could be used to generate recombinant proteins. 
Recombinant protein vaccines generally stimulate superior immunity since the host immune 
system has evolved to recognize these antigens and the purified proteins do not usually cause 
adverse reactions in animals and humans.        
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Figure 1.1:The difference between F. necrophorum subspecies necrophorum and F. 
necrophorum subsecies funduliforme, from a summary of cases. Courtesy of Riordian 
 Importance of outer membrane proteins in Gram-negative bacteria for 
adhesion and infection 
One of the most important and critical events in bacterial pathogenesis is the adhesion of 
the pathogen to host cells. Many Gram-negative bacteria produce outer membrane proteins 
which help the bacteria bind to receptors on the host cell surface and initiate colonization of the 
host. It is this first initial attachment of the pathogen to host cells which help the bacteria in a 
successful colonization of the host. The outer membrane proteins of many bacteria such as the 
OmpA of E. coli (Wang Y. 2002), and FomA (Liu. et al.2013), protein of F. nucleatum are well 
characterized and have been shown to be important for establishing successful host 
colonizations. Greater understanding of F. necrophorum OMP can provide valuable insights into 
disease pathogenesis as well as provide potential targets for vaccine development.        
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Chapter 2 - Abstract 
Liver abscesses are of major economic importance to the cattle industry. Liver abscesses 
are mainly associated with the presence of Fusobacterium necrophorum, a non-spore forming 
and Gram-negative anaerobe. There are two main subspecies of this bacterium, which differ 
molecularly, morphologically, biochemically and in virulence. Previous studies have shown that 
the outer membrane proteins of F. necrophorum subsp. necrophorum are important for its 
successful binding to immobilized bovine adrenal gland capillary endothelial (EJG) cells. An 
outer membrane protein of F. necrophorum subsp. necrophorum with the highest binding 
capacity to EJG cells was characterized. The gene was cloned into pFLAG-CTS vector and 
subsequently expressed on the surface of E. coli BL21 DE3 cells. When E. coli carrying the 
recombinant plasmid was induced using IPTG, it had significantly enhanced binding to 
immobilized EJG cells compared to both the uninduced control and the E. coli carrying control 
vector only. When fixed EJG cells were incubated with purified native outer membrane proteins, 
E. coli carrying the induced recombinant plasmid, showed lowered levels of binding, comparable 
to the uninduced control and the E. coli carrying control vector only. This gain of function by 
recombinant E. coli confirms the ability of this protein to act as an adhesin to help F. 
necrophorum subsp. necrophorum bind to host cells. Functional characterization of this novel 
adhesin further expands our limited understanding of the pathogenesis of this poorly studied but 
economically significant and highly pathogenic bacterium. 
   
 Introduction 
Fusobacterium necrophorum is a Gram-negative, rod shaped and obligate anaerobic 
bacterium which is frequently associated with necrotic infections in animals and humans (1). F. 
necrophorum is classified into two subspecies (11)- subsp necrophorum which is associated with 
liver abscess and foot rot in animals, while subsp funduliforme is associated with necrobacillosis 
and Lemierre’s syndrome in humans. In feedlot cattle, subsp necrophorum is a major cause of 
infections including hepatic abscesses, necrotic laryngitis, resulting from aggressive grain-
feeding programs (2). Foot rot and lameness in dairy and beef cattle and hepatic abscesses in 
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feedlot cattle are of major economic concerns in the cattle industry (2, 3). In feedlots, liver 
abscesses range from 12-32%, depending on various management and dietary factors (2). Liver 
abscesses and subsequently liver condemnations are of major economic concern to beef 
producers and packers, since the liver accounts for roughly 2% of the weight of the carcass. 
In-vitro studies have shown that F. necrophorum uses outer membrane proteins (OMPs) 
to mediate adhesion to bovine adrenal gland capillary endothelial (EJG) cells (4). Four OMPs of 
17, 24, 43 and 74kDa demonstrated an important role in adhesion of bacteria to fixed endothelial 
cells, with the 43kDa protein (FunA) showing the highest affinity for EJG cells. In these studies, 
we cloned the 43kDa protein gene (funA) into pFLAG-CTS expression vector and consequently 
cloned it into E. coli BL21 DE3 cells to characterize the protein. We were able to show that this 
protein expressed in E. coli increases binding of E. coli to EJG cells, when compared to the 
uninduced or control vector expressed in E. coli. We conclude that this 43kDa OMP serves as an 
adhesin for endothelial cells for bovine strains of F. necrophorum. Neutralization of F. 
necrophorum adherence is an attractive strategy to prevent Fusobacterium colonization of the 
liver.    
  
 MATERIALS AND METHODS 
 Bacterial strains 
Fusobacterium necrophorum subsp necrophorum strain 8L1 was used for cloning the 
43kDa gene in this study. 8L1 was grown in pre-reduced, anaerobically sterilized Brain Heart 
Infusion (PRAS-BHI) broth (6). E. coli TOP10 (Invitrogen) was used for cloning and sequencing 
the gene. E. coli BL21DE3 was used for the expression of the recombinant adhesin proteins. 
 
 Isolation of outer membrane proteins 
    Outer membrane proteins from F.  necrophorum subsp. necrophorum strain 8L1 were 
isolated using standard procedure, as described by Osborn and Munson (5). 8L1 was grown 
overnight in 1L of PRAS-BHI. Bacterial cells were harvested by centrifugation at 1,200 RPM for 
15 minutes at 43C. The pelleted cells were resuspended in 10mL cold 0.75M sucrose-10mM tris, 
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pH 7.8. Lysozyme was added at a concentration of 2mg/mL and the cells were incubated on ice 
for 20 minutes. The suspension was diluted with 20 ml of cold 1.5mM EDTA delivered over 15 
minutes. Following the addition of EDTA, the mixture was sonicated in an ice water bath, using 
a 3mm microtip at 20W output pulse settings. The sonication was repeated 10 times and was 
done in 10 second intervals with a minute pause between each sonication. The sonicated liquid 
was then centrifuged at 1,200g for 15 minutes at 43C. The supernatant from the above step was 
centrifuged at 65,000 RPM for 2 hours at 43C.  The membrane pellet was resuspended in a small 
volume of cold 0.25M sucrose and 20mg/mL Triton X 100 (Sigma-Aldrich, St. Louis, MO), and 
incubated for 45 minutes at room temperature to dissolve the inner membrane. The suspension 
was centrifuged at 37,000 RPM for 2 hours. The pellet obtained consisted of the OMP fraction 
and was resuspended in cold STE buffer and stored at -80 until use.  
  
  
 
 Cloning and expression of the 43KDa OMP 
     The  funA gene was amplified from F. necrophorum subsp. necrophorum strain 8L1 
and subsequently cloned, as a HindIII/SalI fragment into the expression vector pFLAG-CTS 
(Sigma-Aldrich, St. Louis, MO) (7). The sequence of the forward and reverse primers was 5’ 
CAT AAGCTT CT GAA ATT ATG CCT GGA CC 3’ and 5’ TAA GTCGAC GAA GCT AAC 
TTT CAT ACC A 3’ respectively, the underlined sequences being the restriction enzyme sites. 
The PCR conditions were as follows: 1 cycle 96˚C for 3 min followed by 35 cycles of 
denaturation at 96˚C for 15 s, annealing at 50˚C for 30 s, and extension at 72˚C for 1 min and a 
final extension at 72°C for 5 min using Ex taq polymerase (Takara Inc., Mountain View, CA). 
The fragment was cloned to include the FLAG sequence at the N-terminal of the protein. The 
plasmid was named pSM2013 and was transformed into E. coli BL21DE3(8) cells. E. coli BL21 
DE3 cells carrying pSM 2013 were now labelled as SM 2013. For expression, SM 2013 or the 
pFLAG control vector were grown in LB broth supplemented with ampicillin at a final 
concentration of 100μg/ml to an OD600 of approximately 0.7 at 37
0
C. IPTG was added to a final 
concentration of 0.5M and protein was expressed for 2 hours at 37
0
C.   
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  Expression and Localization of the expressed protein on the cells surface 
The purified native OMP preparation containing FunA and recombinantly expressed 
FunA protein from E. coli BL21 (DE3) were subjected for SDS-PAGE analysis and blotted on  
nitrocellulose membrane (Whatman Optitran, Dassel, Germany). Mouse antisera recognizing 
FunA protein was produced and was utilized in Western blots to determine if the protein was 
expressed in SM 2013 clone.  
 EJG attachment assay 
 Bovine adrenal gland capillary endothelial cells (EJG) were acquired from ATCC 
(American Type Culture Collection, Manassas, VA), catalog # CRL-8659. Cells were grown and 
maintained in Eagle’s minimum essential medium, supplemented with 10% fetal bovine serum 
and 1% antibiotics per 1 liter of media. The cell media was changed every 3 days until the cells 
formed a monolayer. The cells were then treated with trypsin and were seeded into a 6 well plate 
at 120,000 cells/well and let stand alone for 48 hours to negate the effects of trypsin. 
Forty eight hours post seeding, the EJG cells were fixed with modified Karnovsky’s 
solution(0.1 M cacodylate buffer, 2.5% glutaraldehyde, 2% paraformaldehyde, adjusted to pH 
7.4)(10) for 30 minutes at 43C, and then rinsed three times with double distilled water. Each well 
was then incubated with either the induced or un-induced SM 2013 clone or E. coli BL21DE3 
cells containing the pFLAG-CTS-BAP control vector for 2 hours at 37
0
C. After two hours, the 
wells were washed three times using double distilled water. One ml of LB broth was then added 
to each well, and the cells were scraped off the bottom using a cell scraper. The LB broth 
containing the bacteria and the EJG cells were serially diluted and plated on LB agar plates 
containing ampicillin at a final concentration of 100μg/ml and incubated overnight at 370C. 
Attached bacteria were enumerated by counting colonies.         
 
  OMP inhibition assay 
EJG cells were grown and maintained as previously described, and were seeded into 6 
well plates at 120,000 cells/well and were let to stand alone for 48 hours to negate the effect of 
trypsin. The cells were fixed with modified Karnovsky’s solution for 30 minutes, following three 
rinses with double distilled water. The fixed cells were incubated with 250µl of preparations 
containing OMPs of F. necrophorum subsp. necorphorum strain 8L1 for 2 hours at 43C. The 
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unbound OMPs were washed off three times using double distilled water. The OMP coated cells 
were then incubated with either the induced or un-induced SM 2013 clone or E. coli BL21DE3 
cells containing the pFLAG-CTS control vector for 2 hours at 37
0
C. The attached bacteria were 
enumerated using the procedure previously described.  
  Proteinase K assay 
For surface localization studies, we carried out surface proteolysis using proteinase K 
treatment(9). SM 2013 clone was induced for 2 hours at 37
0
C. The induced intact bacteria were 
then split up into 4 aliquots and subject to 0, 25, 50 or 100 µg/ml of proteinase K for 2 hours. 6 
well plates containing EJG cells at 120,000 cells/ well were then incubated with the treated 
bacteria for 2 hours. The unattached bacteria were washed off using sterile water and the 
attached bacteria were serially diluted and enumerated as described before.  
  Statistical analysis 
All assays were done in triplicate and were repeated a minimum of three times. Graph 
Pad Prism (La Jolla, CA) version 5.1 statistical software was used for the analysis of data.  The 
data was analyzed using repeated measures ANOVA followed by a Tukey posttest. A Pvalue of 
<0.05 was considered significant.  
 Results 
  Expression and Localization of the expressed protein on the cells surface  
The mouse serum recognized the native and recombinant protein according to its 
predicted mass of 43kDa.  This band was not present in E. coli BL21 DE3 cells carrying the 
control plasmid.   
  EJG attachment assay 
When SM2013 was incubated with fixed EJG cells, there was a significant increase in the 
binding of bacterial cells when compared to the EJG cells that were incubated with either 
uninduced SM2013 or the induced or uninduced pFLAG control vector in E. coli BL21DE3 
cells.  
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 OMP inhibition assay 
When SM2013 was incubated with fixed EJG cells that were saturated with the OMP 
preparation, there was a significant (P < 0.0001) decrease in the binding of the bacterial cells 
compared to the control EJG cells that were not saturated with the OMP prep. 
  Proteinase K assay 
The Western blots showed that the proteins were cleaved by proteinase K in a dose 
dependent manner. The protein was also shown to be expressed on the surface of E. coli as the 
intact bacteria were incubated with proteinase K.   
  Discussion 
 Outer membrane proteins (OMPs) are a very important feature of Gram-negativel 
bacteria as they are the first proteins to interact with the host cell surface. These proteins are 
often key for the bacteria in its pathogenesis. OMP are diverse in nature and play multiple roles; 
they may act as adhesins, porins, or receptors for various host molecules, to name a few.  OMP 
of many Gram-negative bacteria have been shown to play an important role in adhesion to host 
cells and subsequently leading to successful colonization and infection of the host (12).  
In the case of Fusobacterium species, OMPs have been shown to be critical for adhesion 
and infection in F. nucleatum(13). It has been shown that OMPs of F. necrophorum subsp. 
necrophorum are important in mediating attachment of bacterial cells to endothelial cells (4). 
Previous studies have shown that pre-incubating F. necrophorum with trypsin reduced the ability 
of the bacteria to bind with fixed EJG cells, showing that bacterial attachment is most likely 
mediated through outer membrane proteins. We were able to successfully clone and express the 
43kDa OMP in the pFLAG-CTS vector. This vector carries the leader region of the OmpA of 
E.coli, which allows expression of the recombinant protein in the periplasm of E.coli. The 
recombinant protein was sequenced and was compared against OMPs of F. necrophorum strain 
8L1 and was successfully identified as the right size band through Western blots. SM 2013 was 
subject to proteolytic degradation in intact bacteria, showing that the OmpA leader sequence was 
successful in sending the recombinant protein to the outer membrane of E. coli.  
When SM2013 was induced, it showed a significantly higher binding to fixed EJG cells, 
when compared against the non-induced SM2013 or the induced or non induced control vector 
expressed in E.coli BL21DE3 cells. Preincubating fixed EJG cells with OMPs of F. 
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necorphorum strain 8L1 reduced the binding efficiency of SM2013 to the EJG cells, indicating 
that some of the OMPs were binding to the same cell receptor.      
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 Figure legends 
Figure 1A. Western blot analysis of recombinant FunA adhesin protein expressed in E. 
coli. Protein ladder (lane A), SM 2013 un-induced (lane B), SM 2013 induced for 2 hours (lane 
C) and protein ladder (lane D). Figure 1B. Coomassie blue staining of the OMP extract. Protein 
ladder (lane A), SM 2013 un-induced (lane B), SM 2013 induced for 2 hours (lane C) and 
protein ladder (lane D).   
Figure 2. EJG attachment assay. The bacteria were incubated with fixed EJG cells and the 
unbound bacteria were washed off using sterile water.  The bound bacteria to the EJG cells were 
removed from the wells and were serially diluted in LB broth and plated on LB agar plates 
containing a final concentration of Ampicillin at 50µg/ml to enumerate surface bound 
bacteria.SM 2013 Induced (lane A), SM 2013 Uninduced (lane B), pFLAG-CTS-BAP Induced 
(lane C), pFLAG-CTS-BAP Uninduced (lane D). 
Figure 3. OMP inhibition assay. Fixed EJG were coated with OMPs from F. 
necrophorum subsp. necrophorum starin 8l1. Unbound OMPs were washed off and bacteria were 
incubated with the pretreated EJG cells. SM 2013 Induced (lane A), SM 2013 Uninduced (lane 
B), pFLAG-CTS-BAP Induced (lane C), pFLAG-CTS-BAP Uninduced (lane D). 
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Figure 4. Proteinase K assay. Intact induced bacteria were incubated with increasing 
concentrations of proteinase K and were then whole cell lysates were subject to Western blot. 
Protein ladder (lane A) 
Figure 5. Proteinase K assay. Intact induced bacteria were incubated with increasing 
concentrations of proteinase K and were then incubated on fixed EJG cells. SM2013 Uninduced 
(lane A), SM2013 Induced (lane B), SM2013 Induced and incubated with 25µg/ml proteinase K 
(lane C), SM2013 Induced and incubated with 50µg/ml proteinase K (lane D), SM2013 Induced 
and incubated with 100µg/ml proteinase K (lane E). A- significantly different from all other 
groups. 
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EJG cells coated with Fusobacterium necrophorum subsp. necrophorum OMPs
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Chapter 3-Summary of my study 
F. necrophorum subsp. necrophorum has been an economically important bacterium to 
the cattle industry ever since feed lots have been used to speed up the production of beef to meet 
the demand of the public for higher amounts of protein to supplement their diets. One way to 
counteract this bacterium would be to reduce the amount of animal protein consumed by people 
and replace it with more sustainable protein such as plant proteins. This would reduce the need 
for animal feedlots, which in turn would decrease the number of cases of F. necrophorum subsp. 
necrophorum infections in cattle. Another attractive strategy would be to not feed these animals 
with highly fermentable grain in feedlots, but give them what they would consume regularly, 
which would be cattle fodder. Since there is a huge opposition to switch from animal protein to 
plant protein and since feedlots are in the business of making copious amounts of money, 
regardless of the cost to the animal on the feedlot or the human who will consume the meat, 
these animals are fattened using every which method, many of them which could be considered 
as borderline illegal and unethical. A third strategy would be to produce a vaccine which could 
successfully prevent the binding of F. necrophorum subsp. necrophorum to the bovine liver and 
therefore prevent abscesses from forming.  
The in-vitro experiments carried out suggest that this 43kDa OMP is a protein which 
binds with high affinity with fixed bovine EJG cells. These results suggest that this could be a 
very important pathogenic mechanism that this bacterium may use to establish initial attachment 
with EJG cells. Once initial attachment is established, the bacterium could use its vast array of 
virulence factors to colonize a host.  
This protein could lead to a successful vaccine, but at the heart of the matter is that, “Is 
this the right way to treat the disease?” If it is mainly a management issue, should one not take a 
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step back and correct what one is doing wrong, instead of try and produce a stop gap method to 
try and treat this disease?  If we do successfully prevent F. necrophorum subsp. necrophorum 
from establishing itself and causing an infection, what guarantees are there that a more potent 
and pathogenic bacteria will not take its place? These are questions which will probably be 
answered in time and I hope that when these questions are answered, that it is not too late to 
undo all the harm we are doing to these animals, to humans and to the planet. 
 
